Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA ZYDUS LIFESCIENCES ALEMBIC PHARMA/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 41.4 18.8 220.1% View Chart
P/BV x 2.5 2.2 111.6% View Chart
Dividend Yield % 2.2 0.7 323.0%  

Financials

 ALEMBIC PHARMA   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-21
ZYDUS LIFESCIENCES
Mar-22
ALEMBIC PHARMA/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs1,150674 170.7%   
Low Rs527331 159.2%   
Sales per share (Unadj.) Rs274.4149.1 184.0%  
Earnings per share (Unadj.) Rs56.722.7 249.6%  
Cash flow per share (Unadj.) Rs66.029.7 222.5%  
Dividends per share (Unadj.) Rs14.002.50 560.0%  
Avg Dividend yield %1.70.5 335.5%  
Book value per share (Unadj.) Rs260.9166.1 157.1%  
Shares outstanding (eoy) m196.561,023.74 19.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.13.4 90.7%   
Avg P/E ratio x14.822.1 66.9%  
P/CF ratio (eoy) x12.716.9 75.0%  
Price / Book Value ratio x3.23.0 106.3%  
Dividend payout %24.711.0 224.4%   
Avg Mkt Cap Rs m164,818514,277 32.0%   
No. of employees `000NANA-   
Total wages/salary Rs m10,51221,777 48.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,931152,652 35.3%  
Other income Rs m8752,354 37.2%   
Total revenues Rs m54,806155,006 35.4%   
Gross profit Rs m14,80134,427 43.0%  
Depreciation Rs m1,8357,130 25.7%   
Interest Rs m1601,270 12.6%   
Profit before tax Rs m13,68128,381 48.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,5335,117 49.5%   
Profit after tax Rs m11,14823,264 47.9%  
Gross profit margin %27.422.6 121.7%  
Effective tax rate %18.518.0 102.7%   
Net profit margin %20.715.2 135.6%  
BALANCE SHEET DATA
Current assets Rs m25,779122,614 21.0%   
Current liabilities Rs m12,80878,394 16.3%   
Net working cap to sales %24.129.0 83.0%  
Current ratio x2.01.6 128.7%  
Inventory Days Days2393 25.3%  
Debtors Days Days280 3.0%  
Net fixed assets Rs m41,311144,382 28.6%   
Share capital Rs m3931,024 38.4%   
"Free" reserves Rs m50,883168,972 30.1%   
Net worth Rs m51,276169,996 30.2%   
Long term debt Rs m1,9993,621 55.2%   
Total assets Rs m67,090266,996 25.1%  
Interest coverage x86.423.3 370.1%   
Debt to equity ratio x00 183.0%  
Sales to assets ratio x0.80.6 140.6%   
Return on assets %16.99.2 183.4%  
Return on equity %21.713.7 158.9%  
Return on capital %26.017.1 152.1%  
Exports to sales %66.80-   
Imports to sales %12.714.3 88.6%   
Exports (fob) Rs m36,020NA-   
Imports (cif) Rs m6,84521,869 31.3%   
Fx inflow Rs m36,02063,065 57.1%   
Fx outflow Rs m6,84521,869 31.3%   
Net fx Rs m29,17541,196 70.8%   
CASH FLOW
From Operations Rs m14,63421,041 69.5%  
From Investments Rs m-8,38811,544 -72.7%  
From Financial Activity Rs m-5,974-8,683 68.8%  
Net Cashflow Rs m26223,729 1.1%  

Share Holding

Indian Promoters % 69.1 74.9 92.3%  
Foreign collaborators % 0.5 0.0 -  
Indian inst/Mut Fund % 18.1 14.9 121.6%  
FIIs % 5.9 2.9 207.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 25.1 121.0%  
Shareholders   101,457 455,624 22.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   DR. REDDYS LAB    SUN PHARMA    CIPLA    LUPIN    AUROBINDO PHARMA    



Today's Market

Sensex Zooms 600 Points, Nifty Tops 17,700; IT and Banking Stocks Rally(10:30 am)

Asian share markets rose today after a slowdown in US inflation boosted hopes that the Federal Reserve will slow down its pace of interest rate hikes.